ArticleEndocrine pathology2019

MiRNA-3653 Is a Potential Tissue Biomarker for Increased Metastatic Risk in Pancreatic Neuroendocrine Tumours.

Preetjote Gill et al.PubMed ↗Publisher ↗

No numbers read from the abstract.